120 related articles for article (PubMed ID: 15242819)
1. Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid.
Michaelis M; Köhler N; Reinisch A; Eikel D; Gravemann U; Doerr HW; Nau H; Cinatl J
Biochem Pharmacol; 2004 Aug; 68(3):531-8. PubMed ID: 15242819
[TBL] [Abstract][Full Text] [Related]
2. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition.
Michaelis M; Suhan T; Reinisch A; Reisenauer A; Fleckenstein C; Eikel D; Gümbel H; Doerr HW; Nau H; Cinatl J
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3451-7. PubMed ID: 16123451
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells.
Michaelis M; Ha TA; Doerr HW; Cinatl J
Cardiovasc Res; 2008 Feb; 77(3):544-50. PubMed ID: 18006438
[TBL] [Abstract][Full Text] [Related]
4. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
Eikel D; Lampen A; Nau H
Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
[TBL] [Abstract][Full Text] [Related]
5. Sodium valproate, an anticonvulsant drug, stimulates human cytomegalovirus replication.
Kuntz-Simon G; Obert G
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1409-15. PubMed ID: 7782769
[TBL] [Abstract][Full Text] [Related]
6. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases.
Göttlicher M
Ann Hematol; 2004; 83 Suppl 1():S91-2. PubMed ID: 15124690
[TBL] [Abstract][Full Text] [Related]
8. Characterization of valproic acid-initiated homologous recombination.
Sha K; Winn LM
Birth Defects Res B Dev Reprod Toxicol; 2010 Apr; 89(2):124-32. PubMed ID: 20437471
[TBL] [Abstract][Full Text] [Related]
9. Experimental study on the action of allitridin against human cytomegalovirus in vitro: Inhibitory effects on immediate-early genes.
Zhen H; Fang F; Ye DY; Shu SN; Zhou YF; Dong YS; Nie XC; Li G
Antiviral Res; 2006 Oct; 72(1):68-74. PubMed ID: 16844239
[TBL] [Abstract][Full Text] [Related]
10. Increase in antiepileptic efficacy during prolonged treatment with valproic acid: role of inhibition of histone deacetylases?
Hoffmann K; Czapp M; Löscher W
Epilepsy Res; 2008 Oct; 81(2-3):107-13. PubMed ID: 18538545
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons.
Kanai H; Sawa A; Chen RW; Leeds P; Chuang DM
Pharmacogenomics J; 2004; 4(5):336-44. PubMed ID: 15289798
[TBL] [Abstract][Full Text] [Related]
12. Carbamazepine is an inhibitor of histone deacetylases.
Beutler AS; Li S; Nicol R; Walsh MJ
Life Sci; 2005 May; 76(26):3107-15. PubMed ID: 15850602
[TBL] [Abstract][Full Text] [Related]
13. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
Lampen A; Göttlicher M; Nau H
ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
[TBL] [Abstract][Full Text] [Related]
14. New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta).
Lampen A; Siehler S; Ellerbeck U; Göttlicher M; Nau H
Toxicol Appl Pharmacol; 1999 Nov; 160(3):238-49. PubMed ID: 10544058
[TBL] [Abstract][Full Text] [Related]
15. Control of human cytomegalovirus gene expression by differential histone modifications during lytic and latent infection of a monocytic cell line.
Ioudinkova E; Arcangeletti MC; Rynditch A; De Conto F; Motta F; Covan S; Pinardi F; Razin SV; Chezzi C
Gene; 2006 Dec; 384():120-8. PubMed ID: 16989963
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid prevents hemorrhage-associated lethality and affects the acetylation pattern of cardiac histones.
Gonzales E; Chen H; Munuve R; Mehrani T; Britten-Webb J; Nadel A; Alam HB; Wherry D; Burris D; Koustova E
Shock; 2006 Apr; 25(4):395-401. PubMed ID: 16670643
[TBL] [Abstract][Full Text] [Related]
17. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
18. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.
Shen HY; Kalda A; Yu L; Ferrara J; Zhu J; Chen JF
Neuroscience; 2008 Dec; 157(3):644-55. PubMed ID: 18848971
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity.
Menegola E; Di Renzo F; Broccia ML; Prudenziati M; Minucci S; Massa V; Giavini E
Birth Defects Res B Dev Reprod Toxicol; 2005 Oct; 74(5):392-8. PubMed ID: 16193500
[TBL] [Abstract][Full Text] [Related]
20. Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation.
Lampen A; Grimaldi PA; Nau H
Mol Pharmacol; 2005 Jul; 68(1):193-203. PubMed ID: 15829700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
